HighTower Advisors Portfolio holdings
AUM
$79.8B
1-Year Return
17.44%
This Quarter Return
+7.52%
1 Year Return
+17.44%
3 Year Return
+65.6%
5 Year Return
+120.67%
10 Year Return
+243.37%
AUM
$70B
AUM Growth
+$5.32B
(+8.2%)
Cap. Flow
-$1.2B
Cap. Flow
% of AUM
-1.71%
Top 10 Holdings %
Top 10 Hldgs %
18.76%
Holding
3,634
New
265
Increased
1,596
Reduced
1,405
Closed
170
Top Buys
| 1 |
Morgan Stanley
MS
|
+$58.2M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$39M |
| 3 |
Invesco S&P MidCap Quality ETF
XMHQ
|
+$37.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$35.2M |
| 5 |
Truist Financial
TFC
|
+$34.5M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.18B |
| 2 |
Apple
AAPL
|
+$73.3M |
| 3 |
Blackrock
BLK
|
+$65.2M |
| 4 |
Lam Research
LRCX
|
+$62.8M |
| 5 |
SharkNinja
SN
|
+$51.4M |
Sector Composition
| 1 | Technology | 13.57% |
| 2 | Financials | 9.89% |
| 3 | Consumer Discretionary | 6.39% |
| 4 | Healthcare | 6.15% |
| 5 | Industrials | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Gores Guggenheim
PSNY
$2.14B
| $49K | ﹤0.01% |
28,882
-961
| -3% | -$1.63K |
|
|
TELL
3352
DELISTED
Tellurian Inc.
TELL
| $46K | ﹤0.01% |
47,005
-8,261
| -15% | -$8.08K |
|
3353
Editas Medicine
EDIT
$248M
| $45K | ﹤0.01% |
13,345
-2,883
| -18% | -$9.72K |
|
|
SNT
3354
Senstar Technologies
SNT
$103M
| $45K | ﹤0.01% |
27,983
| – | – |
|
3355
Anixa Biosciences
ANIX
$96M
| $43K | ﹤0.01% |
13,523
-500
| -4% | -$1.59K |
|
|
BZUN
3356
Baozun
BZUN
$223M
| $42K | ﹤0.01% |
11,732
| – | – |
|
3357
Cardiff Oncology
CRDF
$142M
| $41K | ﹤0.01% |
15,333
-702
| -4% | -$1.88K |
|
3358
FibroGen
FGEN
$46.4M
| $41K | ﹤0.01% |
4,120
| – | – |
|
3359
Lightwave Logic
LWLG
$400M
| $41K | ﹤0.01% |
15,000
| – | – |
|
3360
Martin Midstream Partners
MMLP
$125M
| $41K | ﹤0.01% |
11,402
+14
| +0.1% | +$50 |
|
|
AMPS
3361
DELISTED
Altus Power, Inc.
AMPS
| $41K | ﹤0.01% |
+13,023
| New | +$41K |
|
3362
FingerMotion
FNGR
$106M
| $40K | ﹤0.01% |
18,805
| – | – |
|
3363
Lexaria Bioscience
LEXX
$19.6M
| $40K | ﹤0.01% |
+13,023
| New | +$40K |
|
3364
Aprea Therapeutics
APRE
$9.03M
| $38K | ﹤0.01% |
13,864
| – | – |
|
3365
Enel Chile
ENIC
$5.04B
| $38K | ﹤0.01% |
13,569
+2,317
| +21% | +$6.49K |
|
3366
Gerdau
GGB
$6.19B
| $38K | ﹤0.01% |
+11,132
| New | +$38K |
|
3367
Comstock
LODE
$120M
| $38K | ﹤0.01% |
8,038
+290
| +4% | +$1.37K |
|
3368
Fractyl Health
GUTS
$68.9M
| $38K | ﹤0.01% |
+15,000
| New | +$38K |
|
3369
Fate Therapeutics
FATE
$113M
| $37K | ﹤0.01% |
10,600
-604
| -5% | -$2.11K |
|
3370
Information Services Group
III
$248M
| $37K | ﹤0.01% |
11,212
| – | – |
|
3371
PMV Pharmaceuticals
PMVP
$84.8M
| $37K | ﹤0.01% |
24,880
-150
| -0.6% | -$223 |
|
3372
Digital Turbine
APPS
$495M
| $36K | ﹤0.01% |
11,956
+52
| +0.4% | +$157 |
|
3373
ATAI Life Sciences
ATAI
$1.05B
| $36K | ﹤0.01% |
30,352
-12,700
| -29% | -$15.1K |
|
3374
B2Gold
BTG
$5.6B
| $36K | ﹤0.01% |
+11,645
| New | +$36K |
|
|
GAU
3375
Galiano Gold
GAU
$662M
| $36K | ﹤0.01% |
+25,000
| New | +$36K |
|